BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/22/2022 9:38:18 AM | Browse: 1065 | Download: 2282
Publication Name World Journal of Clinical Oncology
Manuscript ID 74853
Country United States
Received
2022-01-11 15:34
Peer-Review Started
2022-01-11 15:35
First Decision by Editorial Office Director
2022-02-15 00:11
Return for Revision
2022-02-15 00:11
Revised
2022-02-27 01:34
Publication Fee Transferred
Editorial Processing by Scientific Editor
2022-06-06 03:23
Final Academic Decision by Editor-in-Chief
Publication Technical Verification by Editorial Office Director
2022-06-17 23:05
Articles in Press
2022-06-17 23:05
Edit the Manuscript by Language Editor
Typeset the Manuscript
2022-07-01 07:11
Publish the Manuscript Online
2022-07-22 09:38
ISSN 2218-4333 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Retrospective Cohort Study
Article Title Short term safety of coronavirus disease 2019 vaccines in patients with solid tumors receiving systemic therapy
Manuscript Source Invited Manuscript
All Author List Ronald E Cox, Marie Parish, Carolyn Oxencis, Edward Mckenna, Bicky Thapa and Sakti Chakrabarti
ORCID
Author(s) ORCID Number
Ronald E Cox http://orcid.org/0000-0003-1950-6493
Marie Parish http://orcid.org/0000-0003-2561-3965
Carolyn Oxencis http://orcid.org/0000-0003-3431-3016
Edward Mckenna http://orcid.org/0000-0003-0222-7885
Bicky Thapa http://orcid.org/0000-0002-7636-8907
Sakti Chakrabarti http://orcid.org/0000-0002-1582-098X
Funding Agency and Grant Number
Corresponding Author Sakti Chakrabarti, MD, Associate Professor, Department of Hematology and Oncology, Medical College of Wisconsin, 8701 W WATERTOWN PLANK RD, Wauwatosa, WI 53222, United States. schakrabarti@mcw.edu
Key Words COVID-19; Adverse events; Solid tumor; Chemotherapy; Immunotherapy; Targeted therapy
Core Tip The current study evaluates the safety and spectrum of adverse events associated with coronavirus disease 2019 (COVID-19) vaccination in solid tumor patients receiving systemic therapy. While COVID-19 vaccination has been shown to be safe and effective in the healthy population, the data confirming the safety of COVID-19 vaccines in cancer patients are sparse. The lack of safety data in cancer patients has caused significant hesitancy to receive COVID-19 vaccination among the patient population with cancer. Our study showed that the administration of COVID-19 vaccines in solid tumor patients receiving systemic therapy is safe and should be encouraged.
Publish Date 2022-07-22 09:38
Citation Cox RE, Parish M, Oxencis C, Mckenna E, Thapa B, Chakrabarti S. Short term safety of coronavirus disease 2019 vaccines in patients with solid tumors receiving systemic therapy. World J Clin Oncol 2022; 13(7): 599-608
URL https://www.wjgnet.com/2218-4333/full/v13/i7/599.htm
DOI https://dx.doi.org/10.5306/wjco.v13.i7.599
Full Article (PDF) WJCO-13-599.pdf
Full Article (Word) WJCO-13-599.docx